Nara Research & Development Center, Santen Pharmaceutical Co., Ltd, Ikoma, Nara, Japan.
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4479-82. doi: 10.1016/j.bmcl.2010.06.037. Epub 2010 Jun 10.
A three substituted urea derivative, SA13353 (compound 1a), exhibited potent inhibitory activity against lipopolysaccharide (LPS)-induced TNF-alpha production. We focused on the 1,1-substituted moiety (R(1) and R(2)) of SA13353 and investigated substituent effects of this moiety on LPS-induced TNF-alpha production by oral administration in rats. The synthesis of the urea derivatives was performed rapidly in a one-pot manner using a manual synthesizer. Several compounds containing hydrophobic substituents at this moiety showed more potent inhibitory activities than SA13353.
一种三取代脲衍生物 SA13353(化合物 1a),对脂多糖(LPS)诱导的 TNF-α产生具有很强的抑制活性。我们专注于 SA13353 的 1,1-取代部分(R(1)和 R(2)),并通过大鼠口服给药研究了该部分的取代基效应对 LPS 诱导的 TNF-α产生的影响。脲衍生物的合成是使用手动合成仪在一锅法中快速进行的。该部位含有疏水性取代基的几种化合物显示出比 SA13353 更强的抑制活性。